Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,326 recruiting studies in this area right now.
By phase
- Not applicable4,387
- Phase 2611
- Phase 1413
- Phase 3322
- Phase 4268
- Phase 1/Phase 2255
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer340
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer191
- Acute Kidney Injury136
- Endometriosis135
- Chronic Kidney Diseases131
- Pregnancy131
- Breast Cancer106
- Chronic Kidney Disease105
- Infertility95
- Renal Cell Carcinoma80
- Colorectal Cancer76
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Urinary Incontinence64
- Lung Cancer62
Leading sponsors
- Mayo Clinic58
- Assistance Publique - Hôpitaux de Paris47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- AstraZeneca36
- University of Aarhus36
Where studies are running
- California345
- Alabama156
- Texas121
- Massachusetts119
- New York118
- Arizona102
- Florida101
- Colorado90
- Maryland90
- Illinois79
Recruiting studies6,326 total
- NCT07144163RecruitingPhase 3
Atumelnant for adults with classic CAH
This study tests a new drug, atumelnant, for adults with classic congenital adrenal hyperplasia (CAH) caused by 21-OHD. It aims to see if it can help control hormone levels while allowing lower doses of current steroid medications.
Los Angeles, CaliforniaAges 18–74 - NCT07335484Recruiting
New trial nerve stimulation system for bladder or bowel control
This study tests a new temporary nerve stimulation system to see if it can help people with overactive bladder or chronic fecal incontinence. It is a short trial to check if the device works for you.
West Columbia, South CarolinaAges 18 years+ - NCT07546500RecruitingPhase 3
Azenosertib versus chemotherapy for advanced ovarian cancer
This trial tests a new drug called azenosertib against standard chemotherapy for ovarian, fallopian tube, or peritoneal cancer that has come back after platinum-based treatment. The drug targets a specific protein (cyclin E1) found in some tumors and may help stop cancer cells from dividing.
Phoenix, ArizonaAges 18 years+ - NCT06897930RecruitingPhase 1/Phase 2
Testing a new drug for adults with lupus
This trial tests an investigational drug called AZD0120 in adults with lupus that hasn't improved with standard treatments. The goal is to see if it's safe and works well for people with lupus-related organ problems.
San Francisco, CaliforniaAges 18–70 - NCT07587021RecruitingPhase 2
YOLT-203 treatment study for primary hyperoxaluria type 1
This study tests a new drug called YOLT-203 for people with primary hyperoxaluria type 1 (PH1), a rare genetic condition where the body produces too much oxalate, which can damage the kidneys. The trial aims to see if this drug can help reduce oxalate levels and prevent kidney damage.
Birmingham, AlabamaAges 6 years+ - NCT06787612RecruitingPhase 2
New combination for platinum-resistant ovarian cancer
This study tests a new combination treatment (ubamatamab plus another drug) for people with ovarian cancer that no longer responds to platinum chemotherapy. It could be an option if your cancer has kept growing despite prior treatment.
Birmingham, AlabamaAges 18 years+ - NCT07746635Recruiting
Fecal transplant for obese women with polyendocrine metabolic ovarian syndrome
This study tests whether a fecal microbiota transplant (a transfer of healthy gut bacteria) can help women with polyendocrine metabolic ovarian syndrome who are also overweight or obese and planning a frozen embryo transfer. It aims to see if this treatment can improve hormone balance and possibly increase the chance of a successful pregnancy.
Shanghai, Shanghai MunicipalityAges 20–40 - NCT07575308RecruitingPhase 2
ALN-6400 for Heavy Bleeding in von Willebrand Disease
This trial tests a new medicine called ALN-6400 in teenage and adult women with von Willebrand disease (a blood clotting condition) who experience heavy menstrual bleeding. The goal is to see if this treatment can reduce bleeding and improve quality of life.
Los Angeles, CaliforniaAges 16–45 - NCT06789406Recruiting
Testing a new sacral nerve stimulation device for overactive bladder
This study tests a new version of a sacral nerve stimulation device (Axonics model 5101) for people with overactive bladder. It aims to see if the device is safe and works well to reduce sudden urges and frequent urination.
Chicago, IllinoisAges 18 years+ - NCT05417594RecruitingPhase 1/Phase 2
Targeted drug study for advanced cancers with genetic changes
This Phase 1/2 study tests AZD9574 alone or with other cancer treatments in people with advanced solid tumors. It focuses on cancers with specific DNA repair gene changes (like BRCA1/2) or other matching tumor features, and aims to see if the treatment can shrink tumors and improve outcomes.
La Jolla, CaliforniaAges 18–130 - NCT06989112RecruitingPhase 3
First-line treatment for advanced or recurrent endometrial cancer
This trial tests a new combination of drugs for endometrial cancer that has spread or come back. It aims to see if these drugs can shrink tumors and help people live longer. It is for tumors that have a certain protein (HER2) and are mismatch repair proficient (meaning they have a normal DNA repair system).
Tucson, ArizonaAges 18 years+ - NCT07758114Recruiting
Prenatal education on environmental exposures
This study provides education about everyday environmental exposures during pregnancy. It aims to help women make safer choices for their health and their baby's health.
Galveston, TexasAges 18 years+ - NCT07757633Recruiting
Pelvic floor training for urine leaks in women's rugby players
This study tests a pelvic floor muscle training program to improve bladder control and muscle strength in female rugby players. If you leak urine during activity, this could help you manage it while staying active.
GranadaAges 18–45 - NCT05592626RecruitingPhase 1/Phase 2
T cell activator STAR0602 for advanced solid tumors
This study tests an experimental drug called STAR0602 that aims to boost your immune system's T cells to fight advanced solid tumors. It's for patients whose cancer has not responded to standard treatments or for whom such treatments are not suitable.
Sacramento, CaliforniaAges 18 years+ - NCT07195682RecruitingPhase 1
Study of an experimental drug for advanced kidney cancer
This trial tests a new drug (BMS-986506) for people with advanced kidney cancer (clear cell renal cell carcinoma). It aims to see if the drug is safe and effective. Depending on the part of the study, participants may have had prior treatments or be newly diagnosed.
Boston, MassachusettsAges 18 years+ - NCT07105670Recruiting
Replacing high-protein foods in chronic kidney disease
This study looks at how replacing high-protein foods affects people with chronic kidney disease. If you join, you will eat a carefully controlled diet to help researchers understand if changing your protein intake can improve your kidney health.
West Lafayette, IndianaAges 40–70 - NCT07551934Recruiting
Women's Mental Health and Pregnancy Choices in Wartime Ukraine
This study looks at how pregnant women and new mothers in Ukraine are coping emotionally and making decisions about their pregnancies and babies during wartime. Researchers want to understand your experiences to help improve support for women in similar situations.
KyivAges 18 years+ - NCT07318688RecruitingPhase 3
Testing HMI-115 for endometriosis pain
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
Beijing, Beijing MunicipalityAges 18–49 - NCT07634679Recruiting
Bladder Flap Technique and Cesarean Scar Healing
This study compares two surgical techniques used during cesarean delivery to see which one helps the surgical scar heal better and causes fewer problems later. Researchers will follow patients after delivery to check their recovery.
The Bronx, New YorkAges 18 years+ - NCT04963751Recruiting
Pre-surgery counseling for teens having abdominal surgery
This trial offers counseling before surgery for children and teens to help them prepare and understand what to expect. It is designed for people having abdominal surgery under an ERAS pathway, which is a structured plan to support safer, smoother recovery.
Aurora, ColoradoAges 9–17 - NCT05706129RecruitingPhase 1/Phase 2
Testing targeted imaging and therapy for advanced solid tumors
This early-phase study tests two radioactive medicines that first help doctors see tumors and, in some parts of the study, treat them. It may help people with advanced, hard-to-remove cancers that have a specific tumor marker (CA IX).
MelbourneAges 18 years+ - NCT05640999RecruitingPhase 2
Trial for early uterine cancer with POLE mutation after surgery
This Phase 2 trial studies an added (adjuvant) treatment for early-stage uterine cancer that has a specific genetic change called POLE mutation and does not have a p53 abnormal pattern. The goal is to lower the risk of the cancer coming back after surgery.
Anchorage, AlaskaAges 18 years+ - NCT07336134Recruiting
HPV self-test for cervical health
This study offers a way to screen for cervical cancer using an HPV self-test. It is designed for women who may not have had a recent Pap smear and are from certain minority groups.
Philadelphia, PennsylvaniaAges 25–65 - NCT05237141RecruitingPhase 4
Etonogestrel implant for emergency contraception
This trial studies whether placing an etonogestrel hormonal implant can work as emergency contraception and prevent pregnancy. You may be a good candidate if you have regular periods and are not currently pregnant or trying to get pregnant.
Aurora, ColoradoAges 18–40
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,326 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,202 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.